Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS

BACKGROUND: The Xarelto Post-Authorization Safety and Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS) was designed to investigate safety and effectiveness during long-term follow-up of rivaroxaban treatment, using reduced doses compared with other global regions, in Japane...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Takanori, Ogawa, Satoshi, Kitazono, Takanari, Nakagawara, Jyoji, Minematsu, Kazuo, Miyamoto, Susumu, Murakawa, Yuji, Iwashiro, Sanghun, Okayama, Yutaka, Sunaya, Toshiyuki, Hirano, Kazufumi, Hayasaki, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195353/
https://www.ncbi.nlm.nih.gov/pubmed/34115769
http://dx.doi.org/10.1371/journal.pone.0251325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195353/
https://www.ncbi.nlm.nih.gov/pubmed/34115769
http://dx.doi.org/10.1371/journal.pone.0251325

Ejemplares similares